Navigation Links
Biodel Announces $18.5 Million Private Placement
Date:6/22/2012

DANBURY, Conn., June 22, 2012 /PRNewswire/ -- Biodel Inc. (NASDAQ:  BIOD) today announced that it has entered into a definitive securities purchase agreement with a group of institutional investors, including both existing and new investors, for the private placement of approximately 7.9 million shares of its capital stock and warrants to purchase approximately 2.7 million shares of its common stock.  A portion of the shares to be issued will be shares of Biodel's common stock and a portion will be shares of its Series B Preferred Stock.  For each share being purchased, investors will receive a warrant to purchase 0.35 of a share of common stock. 

For each unit consisting of a share and warrant, the investors have agreed to pay a negotiated price of $2.355, resulting in gross proceeds to Biodel, before deducting placement agents' fees and estimated offering expenses of approximately $18.5 million.  The private placement is expected to close on or about June 27, 2012, subject to customary closing conditions.

The Series B Convertible Preferred Stock is non-voting.  Each share of Series B Convertible Preferred Stock is convertible into one share of Biodel's common stock, provided that conversion will be prohibited if, as a result, the holder and its affiliates would beneficially own more than 9.98% of the total number of Biodel shares of common stock outstanding following such conversion.  The per share exercise price of the warrants is $2.66.  The warrants will be exercisable beginning on the original date of issuance and will expire on the date that is five years after the original issue date.

William Blair & Company, L.L.C. acted as Sole Lead Placement Agent and JMP Securities LLC acted as Co-Agent for the private placement.

The securities offered and to be sold by Biodel in this private placement have not been registered under the Securities Act of 1933, as amended (the "Securities Act
'/>"/>

SOURCE Biodel Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
2. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
3. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Berger & Montague, P.C., a full-spectrum class ... one of the largest and most successful whistleblower ... Faruqi, LLP in settling three separate but related ... Cephalon, Inc., and Biogen, Inc., for a total ... agreements, AstraZeneca will pay the largest sum, $46.5 ...
(Date:7/7/2015)... July 7, 2015 A power morcellator lawsuit ... been settled for an undisclosed amount, Bernstein Liebhard LLP ... in March 2014 in the U.S. District Court, Eastern ... of a widower whose wife had died in February ... hysterectomy that involved the use of a power morcellator. ...
(Date:7/7/2015)... Juli 2015 Sequent Medical, ein ... Entwicklung innovativer Geräte für die Behandlung neurovaskulärer ... von R. Michael Kleine in den ... verfügt über eine mehr als 25-jährige Erfahrung ... hat verschiedene globale biomedizinische Unternehmen erfolgreich geleitet ...
Breaking Medicine Technology:AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3
... a wholly-owned subsidiary of Integrated BioPharma,Inc. (NASDAQ: ... of vaccines against HPV, anthrax and plague ... The,studies were conducted by the Fraunhofer USA ... Organization led by Dr.,Vidadi Yusibov, through which ...
... Profile and Excellent,Pharmacokinetic Properties -, RESEARCH TRIANGLE PARK, ... a clinical stage company developing and,commercializing innovative treatments ... top-line results from a Phase I,clinical trial of ... and anxiety. In this study, Tyrima was safe ...
Cached Medicine Technology:Integrated BioPharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
(Date:7/7/2015)... ... July 07, 2015 , ... Safe Catch is setting revolutionary purity ... mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market and Wegmans are ... the technology to test every fish for mercury,” said Safe Catch co-founder Sean Wittenberg. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is ... team. Dr. Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating ... as neurological conditions. , After receiving his Bachelor of Science in Biology from the ...
(Date:7/7/2015)... ... 2015 , ... On June 22nd-26th, 2015, the Cobo Convention ... Baptist Convention 110th Annual Session of the National Baptist Congress of Christian Education ... and their congregations, medical professionals and health-related organizations, this week long event included ...
(Date:7/7/2015)... ... 07, 2015 , ... With a new community program in the San Antonio, ... announced a new charity campaign to raise funds in support of programs for veterans. ... was created especially to care for the special needs of our soldiers. Clear ...
(Date:7/7/2015)... Mateo, CA (PRWEB) , ... July 07, 2015 , ... ... inspire others. California Casualty’s Nominate A Hero program offers a special way ... month a well-deserving hero receives a $250 gift card and their place on the ...
Breaking Medicine News(10 mins):Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3Health News:California Casualty Wants to Know: "Who Is Your Hero?" 2
... vulnerable -- those with low incomes or chronic health problems ... no more risk for cutting back on needed health care ... a new RAND Corporation study. The findings, from the ... plans, contradicts some of the earlier small studies that found ...
... Serena Gordon HealthDay Reporter , SUNDAY, April 17 ... insulin resistance and type 2 diabetes may be linked to ... of this study is trying to shift the emphasis in ... and instead emphasize the role of the immune system in ...
... from the Florida campus of The Scripps Research Institute ... highly selective compounds that effectively suppresses the severity of ... provide new and potentially more effective therapeutic approaches to ... worldwide. The study appeared April 17, 2011, ...
... treatment, cancer still represents one of the most frequent causes of ... this also holds true for pets such as dogs. Each ... half the dogs over 10 years old die because they develop ... CEA is one of the most important markers for tumours. ...
... of several highly publicized suicides by gay teenagers, a new ... is associated with high rates of suicide attempts by lesbian, ... and Suicide Attempts in a Population-Based Sample of LGB Youth," ... It was conducted by by Robert Wood Johnson Foundation Health ...
... April 18, 2011 University of Utah psychologists have learned ... leaves drivers on cell phones prone to traffic accidents and ... The answer: People who fail to see something right ... else have lower "working memory capacity" a measure of ...
Cached Medicine News:Health News:High-deductible health plans pose no special risks to the medically vulnerable, study finds 2Health News:High-deductible health plans pose no special risks to the medically vulnerable, study finds 3Health News:Do Immune System Ills Help Drive Type 2 Diabetes? 2Health News:Do Immune System Ills Help Drive Type 2 Diabetes? 3Health News:Scientists develop compound that effectively halts progression of multiple sclerosis 2Health News:Study links social environment to high attempted suicide rates among gay youth 2Health News:Missing the gorilla 2Health News:Missing the gorilla 3Health News:Missing the gorilla 4
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
250L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: